CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-02-19 | Waksal Harlan Director | Purchase · Common Stock Warrant | +78,581 | 105,769 | ||
| 2010-02-19 | Waksal Harlan Director | Purchase · Common Stock Warrant | +130,969 | 236,738 | ||
| 2010-02-19 | Waksal Harlan Director | Purchase · Common Stock Warrant | +87,313 | 324,051 | ||
| 2010-02-19 | Waksal Harlan Director | Purchase · Common Stock Warrant | +130,969 | 455,020 | ||
| 2010-02-19 | Waksal Harlan Director | Purchase · Common Stock Warrant | +87,313 | 542,333 | ||
| 2010-02-19 | Waksal Harlan Director | Purchase · Convertible Debenture Due 12/31/2010 | +0 | 2,332,259 | ||
| 2010-02-19 | Dondero Richard S VP - Research and Development | Grant or award · Common Stock Option | +300,000 | 807,924 | ||
| 2010-02-19 | BROOKS JOEL CFO and Treasurer | Grant or award · Common Stock Option | +300,000 | 457,500 | ||
| 2010-02-19 | QUICK THOMAS C Director | Grant or award · Common Stock Option | +43,334 | 357,271 | ||
| 2010-02-19 | FORBES CHRISTOPHER Director | Grant or award · Common Stock Option | +54,166 | 458,949 | ||
| 2010-02-19 | Waksal Harlan Director | Grant or award · Common Stock Option | +77,500 | 241,007 | ||
| 2010-02-19 | RECTOR DAVID Director | Grant or award · Common Stock Option | +50,834 | 441,580 | ||
| 2010-02-19 | STALDER RUEDI Director | Grant or award · Common Stock Option | +56,666 | 889,869 | ||
| 2010-02-19 | Van Hulst Jack President and CEO | Purchase | +6,552 | 7,663 | ||
| 2010-02-19 | Van Hulst Jack President and CEO | Purchase · Common Stock Warrant | +3,792 | 5,806 | ||
| 2010-02-19 | Van Hulst Jack President and CEO | Purchase · Common Stock Warrant | +6,320 | 12,126 | ||
| 2010-02-19 | Van Hulst Jack President and CEO | Purchase · Common Stock Warrant | +4,213 | 16,339 | ||
| 2010-02-19 | Van Hulst Jack President and CEO | Purchase · Common Stock | +6,320 | 22,659 | ||
| 2010-02-19 | Van Hulst Jack President and CEO | Purchase · Common Stock Warrant | +4,213 | 26,872 | ||
| 2010-02-19 | Van Hulst Jack President and CEO | Purchase · Convertible Debenture Due 12/31/2010 | +0 | 112,549 |
Page 31 of 38 · 754 trades